László Forró obtained his B.S. at Eötvös Loránd University, Budapest and M.S. at Université Paris XI in physics. He received his PhD at the University of Zagreb in 1985. He was appointed at the Ecole Polytechnique Fédérale de Lausanne in1991 as senior research associate. He was promoted into a full professorship in 2002. Today he holds the chair of Nanostructures and Novel Electronic Materials.In his Laboratory of Physics of Complex Matter (http://lpmc.epfl.ch/) he is leading an interdisciplinary research activity. His honors and awards: Member of the Hungarian, Croatian,Serbian Academies of Sciences.

Nico P.E. Vermeulen (MSc in Chemistry (University of Nijmegen, 1975) and a PhD in Pharmacology (University of Leiden, 1980), was appointed professor of Molecular Toxicology in the Department of Chemistry and Pharmaceutical Sciences (CPS) at VU University Amsterdam, in 1985. Recently, he was Head of the Department of CPS (2009 - ‘15) and also Director of AIMMS (Amsterdam Institute of Molecules, Medicines and Systems; 2010 - ‘17) and, amongst others, coordinator of SafeSciMET, an IMI-JU consortium, and WP-Leader in two other IMI-JU projects: eTOX and MIP-DILI. He was awarded with the European ISSX Scientific Achievement Award (2006), an Honorary Doctorate (University of Copenhagen, 2011) and he is a Life Time Honorary Member of ISSX. He is author/co-author of more than 450 scientific publications in the fields of molecular toxicology/pharmacology, bioanalysis and medicinal chemistry. His general research interests are concerned with the roles molecular and computational toxicology can play in drug discovery, development and safety assessment. More specifically, he is interested in toxication/detoxication mechanisms, in silico and in vitro prediction and screening of ADME-Tox properties, (biocatalytic) metabolite production and profiling and translational biomarkers of adverse drug reactions (ADRs).

Prof. Dr. med. Helmut Greim was chairman of toxicology and director of the Institute of Toxicology and Environmental Hygiene at the Technical University in Munich from 1987 to 2003. He was head of the Institute of Toxicology, GSF-Forschungszentrum für Umwelt und Gesundheit in Neuherberg, Germany, from 1975 to 2000. After receiving M.D. degrees from medical schools in Freiburg and Berlin, Prof. Greim was associate professor of pharmacology and toxicology in the Department of Toxicology at the University of Tübingen and research associate professor of pathology at the Mount Sinai School of Medicine, New York, from 1970 to 1973. He has served on a number of committees, including the German Society of Pharmacology and Toxicology and the Board of Experts on the Environment for the German Federal Ministry of the Environment. He served as chairman of the Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK, 1992 - 2007), was chairman of the German Advisory Committee on Existing Chemicals (BUA, 1998 - 2007) of the Gesellschaft Deutscher Chemiker (GDCh), and was a member of the Enquète-Commission Environment and Health of the German Parliament (1992 – 1994). In 1998 he received the Arnold J. Lehman Award of the Society of Toxicology. He serves as chairman of the EU Scientific Committee on Health and Environmental Risks (SCHER) and is a member of the EU Scientific Committee on Occupational Exposure Limits (SCOEL) and of the Risk Assessment Committee of the European Chemicals Agency (ECHA). Prof. Greim has published over 300 papers in scientific journals

Aristides Tsatsakis is the Director of the Department of Toxicology and Forensic Sciences of the Medical School at the University of Crete and the University Hospital of Heraklion. Dr Tsatsakis has written over 1000 publications (books and abstracts proceedings), over 400 of them in ISI journals. He is holder of several patents and has an extensive array of citations and reads /downloads to his papers. Dr Tsatsakis has given numerous keynote and plenary lectures in international congresses and was the promoter and chair of numerous Symposiums and workshops in International Forum. He has coordinated as a PI in over 50 scientific research and technology projects and has established worldwide collaborations. Aristides Tsatsakis was elected EUROTOX President-Elect in 2012 served as President (2014- 2016) of the Federation of European Toxicologists and European Societies of Toxicology. Dr. Tsatsakis has a long standing activity as Editor in toxicology journals. Prof. Tsatsakis is Emeritus Professor for the Federal Institute of Hygiene and Toxicology in Moscow (2014), Doctor Honoris Causa of the Mendeleev Moscow University (2016), of the Far East Federal University (FEFU), Vladivostok 2017 and of the Carol Davila, in Bucharest (2017). In 2016 was elected Foreign Member of the National Academy of Sciences of Russia (FMRAS) and in 2017 of Fellow Academy of Toxicological Sciences (FATS, USA). Aristides Tsatsakis is the inspirator, founder and chief scientific officer of the University of Crete spin-off Company ToxPlus S.A. The main research interests of Professor Tsatsakis are biomonitoring of various xenobiotics in a variety of biological samples and linking of chemical chronic exposure at low doses with health problems and diseases and risk assessments. He developed numerous biomarkers of exposure and of effects for the pesticide and chemical toxicology area uncovering the mechanistic understanding of the mode of actions and adverse outcome pathways and clinical effects.

Zeliha Selamoglu is a Professor in Medical Biology department of Nigde Ömer Halisdemir University, Turkey. She earned her PhD in Biology from Inonu University, She has published over 100 peerreviewed journal articles with over 950 citations and many technical reports. She is a member of Society for Experimental Biology and Medicine: Associate Membership and European association for cancer research. She has served as Editorial Board member for many Journals.

Elke Dopp is Professor for Hygiene and Environmental Medicine at the Medical Faculty of the University Duisburg-Essen. She has studied Agricultural and Environmental Sciences at the University of Rostock and got her doctoral degree (PhD) as well as the venialegendi (University teaching credentials)for Environmental Toxicology from the University of Rostock. In 2010 she became Professor at the University of Duisburg-Essen. She has published more than 100 papers in reputed journals, has published own book chapters and booksand has been serving as an editorial board member of repute. She was and is also member of national and international expert groups.

A. Wallace Hayes holds appointments at the University of Massachusetts, Institute of Integrated Toxicology, Michigan State University and the University of South Florida College of Public Health. Past positions include Corporate vice president, the Gillette Company; vice president, RJR Nabisco; director, Rohm & Hass; and professor at Alabama, Mississippi, and Wake Forest Universities. He holds degrees from Auburn and Emory Universities and was a National Science Foundation Fellow at Auburn, a National Institutes of Health (NIH) Individual Fellow at Vanderbilt, a North Atlantic Treaty Organization Senior Scientist in the UK, and an NIH Research Career Development awardee. He has served on committees for the National Academy of Sciences, the NIH, the Food and Drug Administration (FDA), the Environmental Protection Agency, and the Department of Defense. Hayes has authored 270 peer-reviewed publications, is editor of Hayes' Principles and Methods of Toxicology (CRC Press, 2014), co-author of Loomis’ Essentials of Toxicology and several toxicology journals. Other past positions include secretary general of the International Union of Toxicology; treasurer of the American Board of Toxicology; president of the American College of Toxicology, the Toxicology Education Foundation, and the Academy of Toxicological Sciences; and councilor of the Society of Toxicology. He is currently the vice president of the Toxicology Forum. He is a diplomat of the Academy of Toxicological Sciences and the American boards of Toxicology, Forensic Medicine, and Forensic Examiners; and a fellow of the Academy of Toxicological Sciences, Royal Society of Biology, the American College of Forensic Examiners, and the American College of Nutrition. He is a registered toxicologist in the European Union and a certified nutrition specialist. Hayes has won the Society of Toxicology's Merit Award, the Mid-Atlantic Society of Toxicology's Ambassador Award, the American College of Toxicology's Distinguished Scientist Award, and the International Dose-Response Society's Outstanding Leadership Award.

Dr Heinonen, Ph.D. in toxicology has adjunct professorships both at the University of Turku (biochemical toxicology) and at the University of Helsinki (biochemistry). She is European registered toxicologist. Dr Heinonen is the director of the Finnish Centre for Alternative Methods, FICAM. Her responsibility has been to set up and is to manage the GLP-grade centre, FICAM. Before FICAM Dr. Heinonen worked in pharma industry for 17 years in various positions such as Study director in in vivo and in vitro non-clinical regulatory (general toxicity and genotoxicity) and biological mechanistic studies, as laboratory head and department manager and also as R&D director. She set up several laboratories into GLP. She gained experience from clinical trials when acting as Clinical study director. Dr Heinonen has participated in several meetings with regulatory bodies (EMEA, FDA, national) with regard to various stages of pharmaceutical development including scientific advices on whole development plan. Before joining to pharmaceutical industry Dr. Heinonen worked at the Institute of Occupational Health performing animal toxicity and in vitro toxicity studies on chemical substances and using that data in carcinogenic risks assessments.

As an epidemiologist and public health physician, Professor Anne-Louise Ponsonby is interested in the broader aspects of public health and preventative medicine. Her work aims to provide new knowledge to assist public health guidelines and policy to achieve reduction in disease burden at the population level. She is also involved with Multiple Sclerosis Australia as an ongoing consultant with regard to health education and promotion activities; a national media spokesperson.

Dr. Mirjana B. Čolović, a research associate has been emoloyed at University of Belgrade, Serbia, from 2005. Her research activities are in the field of enzymology, toxicology, biosensors, physiologically active compounds and their interactions with biomolecules. She has published 38 papers in impacted international journals, 4 chapters in books, 3 articles in national scientific journals, and over 60 abstracts in international and national scientific meetings. She served as a reviewer in over 20 international journals and 9 foreign projects, and has been serving as an editorial board member in 2 international journals.

Danijela Krstić obtained her BSc., MSc. and PhD in biochemistry from the Faculty of Chemistry, University of Belgrade, Serbia. Working as an Associate Professor in the Institute of Medical Chemistry, School of Medicine, University of Belgrade. The topics of her research activities are enzymology, enzyme inhibition and toxic effects of different (organic or inorganic) pharmacologically and physiologically active compounds. She published (author or coauthor) more than 40 scientific papers in international journals.

Olivera Stanojlovic, MD, PhD is full professor of Medical Physiology, head of Laboratory of Neurophysiology at Belgrade University Faculty of Medicine. The topics of her research activities are neurophysisology, somnology, epileptology with focus on neurotoxicological aspects of different compounds. She published (author or coauthor) more than 80 scientific papers in international journals.

Dr. Anamika Tripathi, currently working as an Associate Professor of Botany, Ph. D (BHU), ) Pollution Ecology Research Laboratory, Department of Botany, Hindu college, India. She has done her Ph.D.in Banaras Hindu University, in 1991. Anamika Tripathi specialization areas are Environmental Monitoring and Assessment, Impact of Air Quality on Plants, Soil, Human health and Climate change and E-Waste management. she awarded with Presidential Award in Sofia, Bulgaria (October 2013) and Awarded a Gold Medal from “Academy of Environmental biology” (2011) in Bundelkhand University, Jhansi for the Best Research Paper Publication in Journal of Ecophysiology and Occupational Health, IITR, Luck now, U.P.

Yue received his Ph.D. in Proteomics in 2002 at the University of Michigan, Ann Arbor, USA, where he investigated pathological and physiological mechanisms of Duchenn Muscular Dystrophy (DMD) by identifying and characterizing disease targets, biomarkers, and toxicity pathways associated with the disease onset and progression using functional proteomic approaches. Prior to his Ph.D. studies, he had worked in Walther Oncology Center, Indiana University for four years, where he studied cytokine gene expression in human stem and progenitor cells and gene therapy. Following the completion of his Ph.D. study, Yue moved to Department of Proteomics at Invitrogen (Life Technology), where he worked as a lead scientist for a breast cancer research project focusing on identification of breast cancer biomarkers using Multiplexed Proteomics Technology Platform which was built within the research team. During this period, he also served as a project leader and worked on proteomic assay and technology development. His work resulted in two US patents and four new protein assays that have been widely used in current biomedical and human health research. In 2006, Yue took the position of Principal Investigator at the US Environmental Protection Agency (EPA) to work on the emerging field of toxicoproteomics. His research interests have been on the identification of toxic mechanisms and modes of action of chemical-induced carcinogenesis and identification of protein biomarkers of exposure, toxicity, and effect using improved toxicoproteomic technologies developed by his research team and others. He is currently leading an innovative research project on predictive proteomic risk assessment of chemical mixtures for chemical mixture identification, classification, screening, and prioritization. Yue has received EPA’s Scientific and Technological Achievement Award (STAA) twice. His research efforts and publications have led to the invitations to serve as conference chair, conference keynote speaker, and session chair for many national and international conferences, most notably SETAC, EUROTOX, AES, EPPH, and EOMICS. With regard to the service to the broader scientific community, Yue is currently serving as North America Regional Editor for Journal of Integrated OMICS, Associate Editor and Board Member for Environmental Health and Toxicology,Journal of Genomics and Proteomicsand other prestigious biological journals.

DR Swamy KB, presently working as Professor& HOD of Clinical Anatomy, Lincoln University, Kuala Lumpur, MALAYSIA, has been awarded PhD by Andhra University, India. He has taken his Master’s Degree MS (in Clinical Anatomy) from Andhra Medical College, India, DMCh (Maternal & Child Health) from IGNOU, New Delhi, his Medical Degree (MBBS) in 1976(KMC-Kurnool), He has expertise in Human Genetics, Reproductive Health & Developmental Anatomy and alsohe performed many researches in Herbal Medicine. He has been the genetic counselor for many institutions. He achieved prestigious grants (FRGS,URGS) from Malaysian Government, he has conducted many researches on Herbal Medicine and Diabetes, on “Brain size correlates with Intelligence Quotient (IQ)”, He has been the former founder Anatomist, Professor and Head of the Department for many Medical Schools in India as well as in Malaysia.. He was an Organizing Committee Member for the “9th Euro-Global Summit on Toxicology and Applied Pharmacology held through June 22-24, 2017 at Paris, France. He is an International Editorial Board Member for many reputed journals like Anatomical Society of India (ASI). Recently he has been unanimously elected as an Executive Board Member for Anatomical Society of India(ASI,) He was an Organizing Committee Member for the 8th World Congress on Toxicology at Dubai, UAE “9th EuroGlobal Summit held at Paris and 11th International Congress on Toxicology and Risk Management held on October 10-12, 2017 at London, UK., 11th International Conference on Pharmaco-epidemiology and Clinical Research through October 02-03, 2017 at Kuala Lumpur, Malaysia, He is an Editor for many journals like "Novel Techniques in Nutrition and Food Science". Journal, Herald Scholarly Open Access Journals (Annals Of anatomy & Physiology), Journal Anatomical Society Of India (JASI) and also reviewer for journals like “Food & Chemical Toxicology (Elsevier), "Novel Techniques in Nutrition and Food Science" and many more.

Kazuma Higashisaka, Ph.D., has been an Lecturer at Osaka University since 2017. He graduated from Osaka University in 2009, and received his doctoral degree from Osaka University in 2016. He was a Research Fellow of the Japan Society for the Promotion of Science (2012) and was Assistant Professor at Osaka University from 2012 to 2017. He has published more than 20 papers in reputed journals and he was awarded the Best Poster Award of Safety of Engineered Nanoparticles and Nanotechnologies in 2012.

Jens Christian Larsen graduated from The Technical University of Denmark in 1988 and got a Ph D degree from the Mathematics Institute of the Technical University of Denmark in 1991. After that he had post doc positions for six years and then an assistant professorship from The Royal Veterinary and Agricultural University of Denmark.

Dusan Mladenovic was born in 1980 in Belgrade, Serbia. He is employed as an Assistant Professor at the Institute of Pathophysiology, Faculty of Medicine, University of Belgrade. He has completed his PhD thesis in 2014. in the area of Molecular Medicine. In 2016 and 2017 he spent 10 months at Philipps University of Marburg, Germany, supported by the DAAD (Deutscher Akademischer Austauschdienst) Research Grant for Doctoral Candidates and Young Academics and Scientists. He is an author of 43 articles published in leading world papers, related to the efects of finasteride on the course of hepatic encephalopathy, to the pathogenesis of epilepsy and liver diseases.

Nikolas Harbord, MD completed his medical degree at Robert Wood Johnson Medical School (now Rutgers School of Medicine), USA and Internal Medicine residency and Nephrology fellowship training at Mount Sinai Beth Israel, USA. He is the Chief of the Division of Nephrology and Hypertension at Mount Sinai Beth Israel. He has written and published on the role of the nephrologist in the treatment of the poisoned patient.

Jelena Nesovic Ostojicreceived the M.D., M.Sc., and Ph.D. degrees from the University of Belgrade, Belgrade, Serbia, in 2000, 2005, and 2009. She is currently an Associate Professor of pathophysiology at the Medical Faculty, University of Belgrade. Over 15 years of experience in medical research. Performed basic science research in the field of electrophysiology; can apply appropriate techniques of conventional electrophysiology; research interests are physiology, biophysics and pharmacology of epithelial and excitable membranes. She has published 15 papers in reputed journals. Also large teaching experience in Serbian and English language. Currently engaged in three areas of research: electrophysiology (epithelial and excitable membranes),potassium channels in tubular cells of the kidney (animal models), pathogenesis of acute and chronic renal failure (animal models).

Master’s degree in Pharmacy (1996) and in Biology (1987) at Federico II University of Naples - Italy – where, to date, she is researcher at the Department of Pharmacy. She is author or coauthor of more than 50 research papers and more than 60 communications at symposia. Her main scientific interests are in: i) development of analytical methods for analysis of xenobiotics in various matrices and ii) studies on drug absorption, metabolism and interactions with biological membranes mainly performed by chromatographic methods employing Immobilized Artificial Membrane, Human Serum Albumin and α-Acid Glycoprotein.

Jianlin Lou has completed his PhD from School of Public Health, Zhejiang University, P. R. China and postdoctoral studies from School of Medicine, Zhejiang University, P. R. China. He is the vice dean of Zhejiang Academy of Medical Sciences. He is also the Chairman of Occupational Health and Occupational Medicine Branch under Zhejiang Preventive Medicine Society. He has published more than 40 papers in reputed journals and has been serving as reviewer for more than 15 journals.

Snjezana Petrovic, Molecular biologist and physiologist, has completed her MSc and PhD from Faculty of Biology, University of Belgrade, Serbia. Employed as Associate Research Professor at Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, University of Belgrade. Current (2012-) topics of her research activities are nutrition and metabolism, dietary fats and fatty acids, fatty acid composition of different animal and human tissues. Previous field of work, neuroscience. She has published more than 30 papers in reputed international journals.

Anna Radominska-Pandya, a Professor of Biochemistry and Molecular Biology at UAMS, is the Editor in Chief for Drug Metabolism Review. She received her Ph.D. from the Institute of Biochemistry and Biophysics, Polish Academy of Sciences in Warsaw, Poland. She published 175 papers in peer-reviewed journals and received thirteen R01 grants from NIH and DoD. Research interests include: regulation and suppression of human UGTs and their role as anti-proliferative agents in cancers, interactions between UGTs and cannabinoid receptors, delivery of UGT genes and drugs into cancers using nanomaterial, and the roles of UGTs in biotransformaing drugs including marijuana and synthetic cannabinoids.

Thomas C. Mueller is a Professor in the Department of Plant Sciences at the University of Tennessee. He received his BS from the University of Illinois in Agronomy, his MS from the University of Kentucky in Crop Science, and his PhD from the University of Georgia in Crop Science. His primary research areas are environmental fate of pesticides (especially herbicides) in soils, water systems, and in the air (via drift), and the confirmation and subsequent control of herbicide-resistant weeds. He has published > 120 refereed articles in > 20 different journals. Dr. Mueller has served on an US-EPA Scientific Advisory Board, has served as an associate editor for Weed Science and Weed Technology, has served on the executive board for the Weed Science Society of America as Secretary, and was named a fellow of the WSSA in 2014.

Judith V. Ríos Arana completed her PhD (2003) and M.Sc. (1999) from the University of Texas at El Paso. She is a Full Time Researcher Professor at Chemical and Biological Sciences Department of the Universidad Autónoma de Ciudad Juárez since 2014. Research interest topics include environmental toxicology (aquatic ecotoxicology), limnology of arid zones, and environmental education. She was a Fulbright Fellow on 2010, and has published 13 papers in reputed journals and has been serving as an editorial board member of repute.

Costantinous Sioutas is the Fred champion professor of civil and environmental engineering department at USC. His area of expertise includes development of several particle sampling technologies that have enabled the assessment of the relative toxicity of particulate matters using realistic atmospheres in in-vivo and in-vitro exposure studies funded by US EPA, NIH, and CARB in Southern California. Findings from his work have also been extensively used in the revision of US EPA national air quality standards on particulate matters.

Pharmacist with an MSc and PhD in Pharmaceutical Analysis.Author of 17 novel research papers in the international literature.Quality expert on chemical pharmaceutical products with integrated experience in the Pharmaceutical Quality System and products’ lifecycle management. Began his career as a Laboratory Manager in a company specialized in bioequivalence studies. In 2007 he joined the National Organization for Medicines, served as a Quality Assessor and as a member of the Laboratory of Human Medicines, a part of the OMCL network, conducting among others the post approval market surveillance. Since 2012, successively served all key positions in the field: as an RnD, Bioanalysis, Quality Control and Quality Assurance Senior Manager.

Fiorentina Roviezzo, Associate professor in Pharmacology, has carried out her PhD in part at University of Naples Federico II and in part at William Harvey Research Institute London. She completed postdoctoral studies from University of Salerno. The main focus of her work is investigating on the regulation mechanisms of inflammatory response. She focused her attention on an important eNOS signalling pathway that involves sphingolipids and mostly sphingosine-1-phosphate (S1P). S1P is involved in biological functions including cell growth and survival, differentiation, calcium homeostasis and in smooth muscle contraction. Now, she is focused on lung inflammatory diseases such as Asthma and COPD. To date she was involved in research projects regarding the role of S1P in these pathologies and she has demonstrated a key contribute in the control of airway function. This scientific production is also validated by more than 60 papers published on international journals at impact factor known.

Minerva Martínez Alfaro, Medical Doctor has completed his PhD from University Lyon I Claude Bernard France and postdoctoral studies from UNAM México. Full Time Professor of Toxicology at Universidad de Guanajuato. . She has published more than 24 papers in reputed journals and has been serving as an editorial board member of repute. Sabbatical Professor Laboratory of Molecular Nutrition and Toxicology Tokushima Bunri University (September 2017-july 2018). Research interests:Metal mechanistic Toxicology,Genotoxicology, Molecular Biology and Pharmacology

Jianhui Wu , Professor,has completed his PhD from Fudan University. His research field mainly focus on male reproductive health. He is the deputy director of the Department of Pharmacology & Toxicology, Shanghai Institute of Planned Parenthood Research. He has published more than 100 papers in reputed journals and has been serving as many committee member of repute in China.

Professor Włodzisław Kuliński specjalist in internal medicine , rehabilitation and physical medicine. Academic teacher , working in the Rehabilitation Clinic of the Military Medical Institute in Warsaw and the Faculty of Medicine at Jan Kochanowski University in Kielce. Author of more than 300 publications and more than 200 soldies. Chief editor of Acta Balneologica quarterly and member of Polish and foreign societies.

Dr Cheng Peng is currently working as a Senior Research Fellow at Queensland Alliance for Environmental Health Sciences (QAEHS), joint Research Fellow at UQ Centre for Clinical Research (UQCCR). He is also an adjunct Professor at Shandong Academy of Occupational Health and Occupational Medicine. His research interests include DNA repair proteins, molecular toxicities of environmental factors such as polycyclic aromatic hydrocarbons (PAHs), volatile organic compounds (VOCs), nano-particles and relevant health risk assessment. His also works on screening compounds with potential anti-leukemic and anti-silicosis effects.

objective of this study was to report frequency and ratio of caustic substance ingestion cases and their demographic data that admitted in Loghman Medical Center, as a referral center in toxicological problems Cases and methods: From 2007 to 2010, 300 cases of caustic ingestion were admitted. One hundred and eighty nine men and 109 women ingested caustic ingestion. All demographic data, past medical and past psychiatric history were recorded. gastroesopagheal endoscopy underwent. Caustic injury was defined based on Zargar grading system. Data were analyzed with SPSS 18 software, accordingly.

 HebaLashin is an associate professor in forensic medicine and clinical toxicology, Faculty of Medicine, Tanta University, Egypt. I had my M.B.B.Ch.at 2007 (Excellent with degree of honor) and myMSc, MD in Forensic Medicine and Clinical Toxicology at2012 and 2016 respectively. I had worked as assistant manager of Poison control center, Emergency hospital, Tanta University hospitals. I have high clinical experience in dealing with acute poisoned patients comes to the emergency room with different types of poisons and drug overdoses. I had multiple scientific presentations at national & international conferences.

Jixuan Ma is a postdoctoral studiesand has completed his PhD from Tongji Medical Collage, Huazhong University of Science and Technology.He majors in occupational and environmental health, and devotes to the toxicology and mechanism of crystalline silica on lung lesion.He has published more than 5 papers in reputed journals and has been serving as a reviewer member of scholarly journal.

Meng Yang is a Ph.D student in Tongji Medical Collage, Huazhong University of Science and Technology, China. He majors in occupational and environmental health and devotes to the prevention and treatment of occupational lung disease, especially crystalline silica induced pulmonary fibrosis.

Dr. Hsu has completed his M.A. Medical Sciencedegree at the age of 26 years from National Taiwan University. His main surgical interest are endoscopic prostatic surgery and minimal invasive surgery in onco-urology field. He has published more than 10 papers in reputed journals and is a PhD candidate in Graduate Institute of Clinical Medicine, National Taiwan University.

Eldar Garayev has completed his MD in 2013 from Azerbaijan Medical University.He is a head and professor of General and Toxicological Chemistry department at Azerbaijan Medical University. He is a chairman of the commission for the preliminary examination of dissertations at Azerbaijan Medical University. He has published about 100 papers in reputed journals in several foreighn countries and he is autor of 3 textbooks, 1 study quides and 8 patents. Kamala Badalova has graduated Chemistry Faculty from Baku State University. She was Erasmus Mundus PhD student at Santiago de Compostela University, Spain. She is a lecturer at the Azerbaijan Medical University, General and Toxicological Chemistry Department. Her research releated to chemical-toxicological analysis of some toxic heavy metal compounds, assesment of TiO2 and Ag in human body, microscopic and ultrastructural characteristics of changes in the structural elements of liver under the action of toxic copper (2) sulfate. She has published about 23 papers and short papers in reputed journals and conference materials.

Mahipal Singh Sankhla, Born in 19 May 1994, Udaipur, Rajasthan. He has completed B.Sc. (Hons.) Forensic Science and M.Sc. Forensic Science. Currently he is Pursuing Ph.D. in Forensic Toxicology from Galgotias University, Greater Noida U.P. He has been Awarded as a “Junior Research Fellowship-JRF”, DST-Funded Project at “Malaviya National Institute of Technology- MNIT”, Jaipur and “Young Scientists Award” for Best Paper Presentation in 2nd National Conference on Forensic Science and Criminalistics and “Excellence in Reviewing Award” in International Journal for Innovative Research in Science & Technology (IJIRST). He has Published more then 36 Papers in peer Review International Journals and has been serving as an editorial board member in 14 International Journals and reviewer in 13 International journal.

Wei Li is a PhD student in Tongji Medical Collage, Huazhong University of Science and Technology,Chnia and she has have a bachelor degree in China Medical University. She majors in occupational and environmental health, and devotes to the toxicology and mechanism of crystalline silica on lung lesion. She also participated in the follow-up of the Wuhan-Zhuhai cohort.

I completed my PhD from Cairo University in 2018. I am currently a lecturer in the Pharmacology and Toxicology department, a premier research organization. I published 2 articles related to colorectal cancer in the BMC Cancer journal. I spent 6 months in the institute of molecular medicine in Heinrich Heine University, Düsseldorf, Germany. This was a German Egyptian Research Short term scholarship funded by the DAAD (Deutscher Akademischer Austauchdienst). I have attended several international and national conferences including but not limited to; European cancer congress (ESMO 2015), 12th and 13th congress of EACPT, 2016 and 2017 conference of BGICC.

Background: Drugs have played a major role in defining the sub cultural and counter cultural influences in society. The pervasive availability of psychotropic chemicals can cause a direct physiological and psychological change in the body. The present work is aimed to use laboratory based analyses to determine the prevalence and use pattern of some substances of abuse among a group of acute overdosed patients. Materials and Methods: The study was conducted on patients (n=390) with acute poisoning by some drugs of abuse (Cannabis, benzodiazepines, barbiturates, opiates and ethanol). The patients were from Dakahlia governorate and surrounding governorates. They were admitted to poison unit, emergency hospital, Mansoura University in the period between November 2009 and April 2014. In this study all patients were subjected for detection of drugs of abuse in urine by EMIT system and Gas Chromatography / Mass Spectrometry (GC/MS) for confirmation of the obtained results.

Ioannis Grigoriadis has completed his PharmacistD at the age of 24 years from Aristotle University of Thessaloniki. He is the Chairman of the WAMS International Board for Pharmaceutical Biotechnology and Clinical Pharmacy and the scientific director of Biogenea Pharmaceuticals Ltd, a premier biotechnology personalized cancer vaccination service organization. He has published more than 20 papers in reputed journals and has been serving as an editorial board member of reputeon the collection, processing, cryopreservation and cGMP (according to Good Manufacturing Practice) production -for solely autologous use - of cellular therapeutical solutions from blood (bone marrow, peripheral blood, cord blood) or blood compounds for human use -on stem cell expansion technologies, which were created in the research laboratories ofNASA (National Aeronautics and Space Administration) - on the cGMP production of advanced medicinal products (1394/2007/ΕC) for solely autologous use from skin, dental pulp, cord tissue). (In preclinical-research phase: 2008-2009) - on certified genetic analyses in collaboration with International Referral Centers -on copyright protection according to the American and/or European Copyright Agency

Dong-Yan Huang has completed his master's degree from Fudanuniversity, China and worked in Shanghai Institute of Planned Parenthood Research, China. Her research interests include the etiological mechanism of prostate hyperplasia and the preclinical safety evaluation of new drugs. She Participated in complete national natural fund project, Shanghai talent development fund projects and projects of Shanghai r&d public service platform,etc., published 14 papers, and applied for 2 national invention patents.

Chen Lifen, master of biology, now works in the Pharmacology and Toxicology Research Laboratory of Shanghai Institute of Planned Parenthood Research. She is mainly engaged in the toxicology and pharmacology research of reproductive drugs, reproductive disease model, and is in charge of genetic toxicology projects and research interns.

Alina Martynova has completed her PhD in Pacific State Medical University (Vladivostok, Russia), published articles in reputed journals and specializing in projects on toxicology and microbiology.

Dr. Sandra Mahr did her PhD and postdoctoral studies at the German Rheumatism research Center, Berlin, Germany and at the Institute of Immunology, University of Rostock, Germany. Afterwards she worked in pharmaceutical research and development at NOXXON Pharma AG, Berlin, Germany for several years. She is regulatory affairs consultant (clinical expert) and one of the managing directors of Riegler-Klar & Partner Pharma-Consulting GbR in Potsdam, Germany, providing consulting services in drug regulatory affairs. In 2018, she prepared her master thesis in drug regulatory affairs in the area of regulatory toxicity testing.

Sangare-Tigori B. has completed her PhD from University of Côte d’Ivoire. She is teacher of toxicology in the School of Pharmacy. She has published more than 20 papers in reputed journals and has been serving as an editorial board member of repute in Côte d’Ivoire, Benin and Cameroon.

John KanayochukwuNduka (PhD) was the immediate past Head of Department of Pure and Industrial Chemistryof NnamdiAzikiwe University, Awka Nigeria. He was mentored by Prof. OrishOrisakwe and has published more than 30 academic manuscript in reputable international journals and with an H-index of 10 in science direct. He has co-authored internationally published book and book chapters and served as both reviewer and editorial board of some local and international academic journals.

Olugbenga has completed his PhD from Stellenbosch University, Stellenbosch South Africa and postdoctoral studies from University of Saskatchewan, Canada, and ECT Oekotoxikologie GmbH, Florsheim Germany. He is a visiting Scholar at Obafemi Awolowo University, Ile-Ife, Nigeria. He has published more than 25 papers in reputed journals and has been serving as an editorial board member of repute of the journal Environtropica. Atinuke is currently ss PhD student at the University of Queensland, Brisbane, Australia

Dr. Nasim Zamani is an assistant professor of clinical toxicology in the biggest University-affiliated hospital poison center in the world. She was trained as a fellowship of clinical toxicology in Shahid Behehshti University of Medical Sciences. Her fields of interest are toxic alcohols, opioids, and heavy metal poisonings and reflected in more than 100 published articles in these fields as well as other fields of clinical toxicology.

Seyed Nasser Ostad received his PharmD from Tehran University of Medical Science (TUMS) in 1987 and his PhD in Cellular and Molecular Toxicology from University of Brighton, England in 1996. From 2006, he is a professor in Toxicology at TUMS.His research interests are rational and accelerated development of new drugs and natural agents for cancer therapy, development of new genetic markers for cancer prognosis, development of new cell surface markers, and prediction of response and toxicity of anticancer agents.

Zhongjun Du has completed his PhD at the age of 32 years from Jilin Universityand postdoctoral studies from Shandong University of Traditonal Chinese Medicine. He is the director of Department of Toxicology, Shandong Academy of Occupational Health and Occupational Medicine, an excellent research institute of Occupational Health and Toxicology. He has published more than 20 papers in reputed journals.

Hua Shao has completed his PhD at the age of 34 years from Shandong University. He is the dean of Shandong Academy of Occupational Health and Occupational Medicine, an excellent research institute of Occupational Health and Toxicology. He has published more than 100 papers in reputed journals and has been serving as an editorial board member of repute.